Chronic Lymphocytic Leukemia-CLL
Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer that primarily affects B-lymphocytes, causing abnormal accumulation in the bone marrow and blood.
CLL often progresses slowly, and some patients may not require immediate treatment. For those who do, therapy may include chemotherapy, targeted therapy, immunotherapy, or stem cell transplantation.
Causes and Risk Factors of CLL
- Genetic predisposition: Family history may increase susceptibility.
- Age: Typically diagnosed in individuals over 60 years.
- Environmental exposures: Certain chemicals or radiation may contribute to risk.
Symptoms and Diagnosis
- Swollen lymph nodes
- Fatigue and weakness
- Frequent infections
- Unexplained weight loss or night sweats
Treatment Options for CLL
- Watchful waiting: For slow-progressing cases without significant symptoms.
- Chemotherapy: To reduce abnormal lymphocyte count.
- Targeted therapy and immunotherapy: To specifically attack CLL cells and support immune response.
Why Choose Us for CLL
CureU Healthcare offers expert hematology-oncology specialists, advanced diagnostics, and personalized treatment plans to manage CLL effectively.
Conclusion
CLL is a slow-progressing blood cancer that requires careful monitoring and treatment. CureU Healthcare provides precise, patient-centered care to optimize outcomes.
